abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip
otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea
otsuka glucose injection 10% (20ml) (大塚糖液10%(20ml))
otsuka pharmaceutical factory, inc. - purified glucose - injection
otsuka glucose injection 5% (100ml) (大塚糖液5%(100ml))
otsuka pharmaceutical factory, inc. - purified glucose - injection
glucose solution for injection 50
otsuka pharmaceutical india private limited, india - glucose anhydrous - solution for injection - 50
glucose intravenous infusion bp (100 g/l) - 10 d solution
otsuka pharmaceutical india private limited, india - glucose anhydrous - solution - 100
otsuka sodium chloride injection 10% (大塚食塩注10%)
otsuka pharmaceutical factory, inc. - sodium chloride - injection
glucose intravenous infusion bp 5%
luen wah medical company (singapore) private limited - glucose anhydrous - injection - 50 g/1000 ml - glucose anhydrous 50 g/1000 ml
celemin 10 plus 10% w/ v 10% w/v intravenous injection
otsuka (phils.) pharmaceutical, inc.; distributor: zyre pharmaceutical corp. - amino acids , electrolytes - 10% w/v intravenous injection - 10% w/ v
tna peri injection
claris otsuka private limited village - vasna chacharwadi tal. sanand - amino acids anhydrous glucose bp soybean oil usp - injection - 10% amino acid + 10% dextrose + 20% fat emulsion - intravenous solutions: solutions for parenteral
magnesium sulfate 10% injection u.s.p 27
otsuka egypt - injection - 10 %